The Neighborly Drug Dealer

An Open Dialogue and Update on Azalea Drugs

28 min · 28. touko 2025
jakson An Open Dialogue and Update on Azalea Drugs kansikuva

Kuvaus

Join us on this special episode of The Neighborly Drug Dealer, as Dr. Morgan Fordham gives an update on Azalea Drugs and the pharmacy construction project.

Kommentit

0

Ole ensimmäinen kommentoija

Rekisteröidy nyt ja liity The Neighborly Drug Dealer-yhteisöön!

Aloita maksutta

14 vrk ilmainen kokeilu

Kokeilun jälkeen 7,99 € / kuukausi. · Peru milloin tahansa

  • Podimon podcastit
  • 20 kuunteluaikaa / kuukausi
  • Lataa offline-käyttöön

Kaikki jaksot

22 jaksot

jakson GLP-1 Crackdown: What the FDA Really Means & Why Compounding Still Matters kansikuva

GLP-1 Crackdown: What the FDA Really Means & Why Compounding Still Matters

There’s been a lot of noise lately around semaglutide, tirzepatide, and other GLP-1 medications—especially as the FDA cracks down on certain compounded versions. But what’s really going on? And what should patients and providers know? In this solo episode, I unpack the truth behind the headlines. We’ll clarify what GLP-1 medications actually are (hint: they’re not insulin), why they’re in such high demand, and how compounding pharmacies legally stepped in during national shortages. I’ll also break down the difference between 503A and 503B pharmacies and share how to spot quality in compounded meds. Whether you’re a patient, provider, or pharmacy pro, this episode clears the fog around GLP-1s and gives you real tools to stay informed.

8. heinä 202534 min